Gainers
-
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 100 percent to close at $2.80 on Thursday after the company
reported that it has established a Scientific Advisory Board and named Dr. Giovanni Addolorato as its first member and
Chairperson.
-
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) surged 83.42 percent to close at $6.97 on Thursday. The biopharma
company announced Thursday ahead of the market open that the FDA has formally communicated through the minutes of an Oct. 29
Breakthrough Therapy Type B Clinical guidance meeting that it has accepted the study design of the new Phase 3 RECOVERY trial
evaluating the company's TNX-102 SL as a bedtime treatment option for post-traumatic stress disorder, or PTSD.
-
Kirkland's, Inc. (NASDAQ: KIRK) shares
gained 34.13 percent to close at $10.10 after reporting upbeat Q3 results.
-
Titan Machinery Inc (NASDAQ: TITN)
gained 25.6 percent to close at $17.81 following upbeat Q3 results.
-
Tech Data Corp (NASDAQ: TECD) rose 22
percent to close at $89.89 after the company reported upbeat results for its third quarter.
-
Realm Therapeutics Plc (NASDAQ: RLM)
rose 21.62 percent to close at $3.15 following earlier press release highlighting updates on strategic review. Realm said it is
considering separate sale of its HOCl-related assets, including Vashe royalty stream.
-
Arsanis, Inc. (NASDAQ: ASNS) shares
rose 21.24 percent to close at $3.71 on Thursday after dipping 25.73 percent on Wednesday.
-
Abercrombie & Fitch Co. (NYSE: ANF) rose
20.91 percent to close at $20.70 after the company posted stronger-than-expected Q3 results.
-
iCAD, Inc. (NASDAQ: ICAD) surged 16.31
percent to close at $3.78.
-
Adaptimmune Therapeutics plc (NASDAQ: ADAP) rose 15.53 percent to close at $5.95.
-
Pfenex Inc. (NYSE: PFNX) gained 14.54
percent to close at $4.57.
-
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) surged 14.48 percent to close at $2.570.
-
Alliqua BioMedical, Inc. (NASDAQ: ALQA) rose 14.29 percent to close at $3.04 after jumping 63.19 percent on
Wednesday.
-
BioHiTech Global, Inc. (NASDAQ: BHTG)
gained 13.25 percent to close at $2.82 after the company announced plans to acquire additional 26.8% ownership in HEBioT
Renewable Resource Recovery facility.
-
Dynagas LNG Partners LP (NYSE: DLNG)
climbed 12.75 percent to close at $4.60.
-
Caladrius Biosciences, Inc. (NASDAQ: CLBS) gained 12.64 percent to close at $4.99.
-
LifeVantage Corporation (NASDAQ: LFVN)
shares jumped 11.82 percent to close at $13.34 on Thursday.
-
RF Industries, Ltd. (NASDAQ: RFIL)
gained 11.77 percent to close at $8.83.
-
Bloom Energy Corporation (NYSE: BE) gained
11.72 percent to close at $17.26.
-
ContraFect Corporation (NASDAQ: CFRX)
surged 11.27 percent to close at $2.37.
-
Community Health Systems, Inc. (NYSE: CYH) shares climbed 11 percent to close at $4.44.
-
Chico's FAS, Inc. (NYSE: CHS) shares
gained 10.65 percent to close at $5.30.
-
Semtech Corporation (NASDAQ: SMTC)
rose 7.62 percent to close at $51.81 following Q3 earnings.
-
SilverCrest Metals Inc. (NYSE: SILV)
shares gained 5.6 percent to close at $2.45 after the company disclosed a C$31 million strategic investment by SSR Mining.
Losers
-
ShiftPixy Inc (NASDAQ: PIXY) shares
tumbled 32.35 percent to close at $2.99 on Thursday after reporting fourth-quarter results.
-
Tilly's Inc(NYSE: TLYS) dropped 21.1
percent to close at $12.04. Tilly’s reported upbeat earnings for its third quarter, while sales missed estimates. The company
issued weak fourth-quarter earnings guidance.
-
SPI Energy Co., Ltd. (NASDAQ: SPI)
shares fell 18.14 percent to close at $1.76.
-
YETI Holdings, Inc. (NYSE: YETI) dipped
16.15 percent to close at $16.10 after reporting Q3 results.
-
Bitauto Holdings Limited (NYSE: BITA)
dropped 12.31 percent to close at $17.52. Credit Suisse downgraded Bitauto from Outperform to Neutral.
-
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) dipped 11.5 percent to close at $2.77. Catalyst Pharmaceuticals, which
rallied over 7.5 percent Wednesday amid a clarification from the company concerning an unintended updation regarding FDA
approval for its Firdapse, announced after the close the regulatory body did approve its autoimmune disorder medication for
Lambert-Eaton myasthenic syndrome, or LEMS, in adults.
-
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) fell 11.3 percent to close at $2.12.
-
Chaparral Energy, Inc. (NYSE: CHAP)
dipped 11.27 percent to close at $10.86.
-
Hertz Global Holdings, Inc. (NYSE: HTZ)
fell 11.06 percent to close at $18.65.
-
Hibbett Sports, Inc. (NASDAQ: HIBB)
shares declined 10.81 percent to close at $15.51.
-
Globus Maritime Limited (NASDAQ: GLBS)
declined 10.56 percent to close at $4.32.
-
Sphere 3D Corp. (NASDAQ: ANY) shares
fell 10.29 percent to close at $6.28.
-
NF Energy Saving Corporation (NASDAQ: NFEC) dropped 10.19 percent to close at $9.34.
-
PPDAI Group Inc. (NYSE: PPDF) shares
dipped 10.05 percent to close at $5.64.
-
Intelsat S.A. (NYSE: I) shares fell 9.93
percent to close at $26.22 after reporting secondary offering of common shares by certain shareholders.
-
RYB Education Inc - ADR (NYSE: RYB)
shares fell 9.48 percent to close at $7.64 following Q3 results. RYB Education reported Q3 earnings of $0.06 per share on sales
of $35.257 million.
-
Noodles & Company (NASDAQ: NDLS)
declined 9.46 percent to close at $8.42.
-
Quest Diagnostics Incorporated (NYSE: DGX) dropped 9.27 percent to close at $87.94 after the company cut FY18 sales
guidance.
-
Build-A-Bear Workshop, Inc. (NYSE: BBW)
shares declined 8.94 percent to close at $6.72 following Q3 results. Build-A-Bear posted a Q3 loss of $0.42 per share on sales
of $68.694 million.
-
Vaxart, Inc. (NASDAQ: VXRT) shares
fell 7.81 percent to close at $2.95.
-
Pyxus International, Inc. (NYSE: PYX)
dropped 7.74 percent to close at $14.43.
-
Cision Ltd. (NYSE: CISN) shares fell
6.74 percent to close at $12.18.
-
Express, Inc. (NYSE: EXPR) dropped 5.03
percent to close at $6.80. Express reported upbeat Q3 results, but issued weak forecast for the current quarter.
-
Dick's Sporting Goods, Inc. (NYSE: DKS)
dipped 4.67 percent to close at $35.52. JP Morgan downgraded Dick's Sporting from Overweight to Neutral and lowered the price
target from $46 to $41.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.